Search Results
Dr. Burris on the Potential of PARP Inhibitors in TNBC
Dr. Burris on Treatment Considerations in TNBC
Dr. Burris on Recent Advances in TNBC
An Expert Explains the Three Major Treatment Modalities in Triple Negative Breast Cancer
Treatment advances in TNBC
Advances in Treatment of Triple-Negative Breast Cancer: A Success Story
Treatment Options in Metastatic TNBC
Precision Medicine in the Treatment of Breast Cancer of Relating Treatments to Mutation
San Antonio Roundtable, Part 3: Trastuzumab, Bevacizumab, and Angiogenesis Inhibitors
Dr. Francisco J. Esteva Gives an Update from the ASCO 2019 Meeting
Exceptional Responders in Breast Cancer
Exploratory analysis of KEYNOTE-522: EFS after neoadjuvant pembro + chemo Vs chemo for early TNBC
